All News | FDA

Advertising & Promotion

Jan 13, 2014
Draft Outlines Submission Standards for Interactive Promos, Including Real-Time Content
Jan 3, 2014
OPDP Takes DaraBiosciences To Task With Untitled Letter on Superiority Claims
Dec 31, 2013
CFSAN Warning Letter Targets Supplement Manufacturer Over Drug-like Claims on Sites
Dec 31, 2013
Abbott Settles False Claims Act Charges for $5.475 Million; Kickbacks, Off-label Sales Alleged
Dec 27, 2013
Three New Untitled Letters From OPDP Target Web Page, Webinar Promo and Letter to Doctors
Dec 20, 2013
Justice Dept.: More Than $2.2 Billion Recovered From Off-label Promotion Cases in Fiscal 2013
Dec 17, 2013
GSK Looks To Cut Promotional Payments to Doctors, End Sales Targets for Detailers
Dec 12, 2013
Pew Report Pushes Teaching Hospitals To Ban Drug Detailers, Limit Access for Device Detailers
Dec 11, 2013
Supreme Court Rejects Pfizer’s Request for Re-hearing in Neurontin Marketing Trial
Dec 9, 2013
Agency Tweaks Form FDA 2253 With New Format, Revised Instructions

Good Clinical Practice

Feb 4, 2016
Georgia House Health Committee Offers Revised ‘Right-to-Try’ Bill
Feb 4, 2016
FDA Continues To Clarify 15-day Safety Reporting Requirements
Feb 2, 2016
Second ‘Right-to-Try’ Bill Introduced in Washington
Jan 29, 2016
HHS Seeks SACHRP Nominations
Jan 29, 2016
Education Prior to First Oncology Visit Aids Patient Understanding of Cancer Trials
Jan 29, 2016
‘Right-to-Try’ Bill Introduced in West Virginia
Jan 28, 2016
‘Right-to-Try’ Bill Introduced in Washington State Senate
Jan 28, 2016
FDA Looks To Improve Trial Diversity
Jan 27, 2016
Study Examines Characteristics of Marketing Trials
Jan 26, 2016
‘Right-to-Try’ Bills Introduced in Hawaii

FDA Regulation & Enforcement

Nov 8, 2018
FDA Posts Two Guidances on New Facts Panels
Nov 7, 2018
Gottlieb: FDA Will Expand ‘Appropriate’ Use of Mandatory Food Product Recall Authority Under FSMA
Nov 2, 2018
Australia Posts Changes to Advertising Code
Nov 1, 2018
OPDP Cites Web Page for Lack of Risk Information
Nov 1, 2018
AdvaMed Advocates Three New Anti-Kickback Statute Safe Harbors To Help Advance Value-Based Care
Nov 1, 2018
FDA Has New Enforcement Authorities Under Bipartisan Legislation Addressing Opioid Crisis
Oct 30, 2018
FDA Takes First Step Toward Allergen Labeling for Sesame
Oct 30, 2018
ERSP Recommends Changes in Claims in Online Ads for Vitamin Vaporizer
Oct 29, 2018
Abbott To Pay $25 Million To Resolve Kickback and Off-label Marketing Case
Oct 29, 2018
McCaskill Releases Report on Insys Sales Strategy

Copyright © Thompson FDA, a division of CBIS. All rights reserved.